1. Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers. Issue 2 (9th August 2018) Authors: Yang, Hua; Merica, Elizabeth; Chen, Yue; Cohen, Marvin; Goldwater, Ronald; Kosinski, Penelope A.; Kung, Charles; Yuan, Zheng (Jason); Silverman, Lee; Goldwasser, Meredith; Silver, Bruce A.; Agresta, Sam; Barbier, Ann J. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 2(2019) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗